The researchers compared anti-CGRP mAbs with other drugs for the prevention of episodic and chronic migraine using a likelihood to help versus harm analysis.
One aim of this study was to compare breast cancer survivors and HIV patients, both with neuropathic pain, with regard to psychological factors and health-related quality of life.
The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.